A case-control study on the diagnostic role of Omega-3 fatty acid levels in erythrocyte membranes of critically ill patients

A case-control study on the diagnostic role of Omega-3 fatty acid levels in erythrocyte membranes of critically ill patients

Abstract This study aimed to investigate the erythrocyte Omega-3 fatty acid index as a potential biomarker for clinical severity, nutritional status, and mortality risk in critically ill patients admitted to the intensive care unit (ICU). Using a case-control design, we evaluated 86 ICU patients wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohsen Dorchin, Milad Nasiri-Jounaghani, Fatemeh-Sadat Hashemi-Javaheri, Mohammad Safarian, Ahmad Bagheri-Moghaddam, Abdolreza Norouzy, Majid Khadem-Rezaiyan, Samin Hejazi, Mostafa Arabi
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Omega-3 index
Critically ill patients
Erythrocyte fatty acids
Inflammation biomarkers
Intensive care unit
Online Access:https://doi.org/10.1038/s41598-025-09391-3
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract This study aimed to investigate the erythrocyte Omega-3 fatty acid index as a potential biomarker for clinical severity, nutritional status, and mortality risk in critically ill patients admitted to the intensive care unit (ICU). Using a case-control design, we evaluated 86 ICU patients with severe clinical conditions, including cardiovascular, respiratory, and oncological complications. Blood samples were analyzed to quantify eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels in erythrocyte membranes. Clinical outcomes were assessed at 28 and 60 days to determine correlations with fatty acid profiles. Our findings showed no significant differences in EPA, DHA, or combined Omega-3 index levels between survivors and non-survivors. Additionally, no meaningful correlations were found between Omega-3 indices and clinical severity scores (APACHE II, SOFA) or nutritional assessments. These results suggest that erythrocyte Omega-3 fatty acid levels may not be reliable prognostic markers of mortality or clinical trajectory in critically ill ICU patients. Although Omega-3 fatty acids play a role in inflammatory modulation, their membrane concentrations do not appear to reflect patient outcomes in this setting. Further research is warranted to explore alternative biomarkers or to incorporate broader inflammatory indices in critical care prognostication.
ISSN:2045-2322

Similar Items